Physician profile
Gary S Besser
NPI 1992809982
$7,747.00
in general payments reported to CMS, 2019-2025
38 companies · $1,172 in 2025
The $1,172 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,320 · 2020: $672 · 2021: $1,001 · 2022: $1,352 · 2023: $1,179 · 2024: $1,051 · 2025: $1,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,402.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,181.26 | 2019-2024 | Lo Loestrin Fe, Orilissa, Liletta |
| Astellas Pharma US INC | $1,057.18 | 2019-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $813.34 | 2023-2025 | Gemtesa, Myfembree |
| Mayne Pharma Commercial LLC | $585.98 | 2021-2025 | |
| Pfizer INC. | $418.84 | 2019-2025 | |
| Therapeuticsmd, INC. | $397.01 | 2019-2022 | |
| Avion Pharmaceuticals | $339.21 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $329.54 | 2019-2025 | |
| Exact Sciences Corporation | $318.75 | 2023-2025 | Cologuard Collection Kit |
| Urovant Sciences INC | $292.83 | 2021-2022 | |
| Biogen, INC. | $245.54 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $229.02 | 2021-2022 | |
| Exeltis, USA INC. | $220.28 | 2019-2025 | Slynd |
| Coopersurgical, INC. | $161.51 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Merck Sharp & Dohme LLC | $158.66 | 2019-2023 | Gardasil 9 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $125.14 | 2020-2022 | |
| Scynexis, INC. | $98.88 | 2022 | |
| Vertical Pharmaceuticals, LLC | $83.03 | 2019 | |
| Millicent US INC | $72.53 | 2019-2025 | Intrarosa, Femlyv |
| Amag Pharmaceuticals, INC. | $65.74 | 2019-2020 | |
| Aspira Women'S Health INC | $65.23 | 2024-2025 | Ova1 |
| Agile Therapeutics, INC. | $59.50 | 2021-2022 | |
| Duchesnay USA Incorporated | $56.91 | 2019 | |
| Organon LLC | $48.56 | 2022-2025 | Nexplanon |
| Daiichi Sankyo INC. | $47.16 | 2019 | |
| Medtronic Vascular, INC. | $34.74 | 2019 | |
| Lupin INC. | $32.40 | 2020-2021 | |
| Coloplast Corp | $31.57 | 2019-2020 | |
| Allergan, INC. | $27.00 | 2019-2020 | |
| Baxter Healthcare | $25.03 | 2019 | |
| Medicem INC. | $23.16 | 2020 | |
| Sanara Medtech INC. | $21.27 | 2021 | |
| Medline Industries LP | $20.46 | 2019 | |
| Innovation Technologies INC | $17.12 | 2025 | Irrisept |
| Mallinckrodt Enterprises LLC | $13.72 | 2019 | |
| Olympus America INC. | $12.99 | 2019 | |
| Ascend Therapeutics US, LLC | $11.70 | 2019 | |
| Meditrina | $4.21 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Besser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.